Clinical Trial Update: EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial compares EF5 with other methods for detecting oxygen levels in tumor cells in patients with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• EF5

Snippet

Sponsor: David M. Brizel, MD | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED